MSL
RGEN icon

Mackay Shields LLC’s Repligen RGEN Stock Holding History

Mackay Shields LLC’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,200
Closed -$766K – 1530
2020
Q2 		$766K Sell
6,200
-15,900
-72% -$1.87M 0.01% 1107
2020
Q1 		$2.13M Buy
22,100
+13,799
+166% +$1.33M 0.02% 642
2019
Q4 		$768K Sell
8,301
-28,410
-77% -$2.39M 0.01% 1114
2019
Q3 		$2.82M Sell
36,711
-2,600
-7% -$227K 0.02% 757
2019
Q2 		$3.38M Buy
39,311
+22,037
+128% +$1.5M 0.02% 706
2019
Q1 		$1.02M Sell
17,274
-1,500
-8% -$86.3K 0.01% 992
2018
Q4 		$990K Sell
18,774
-8,132
-30% -$477K 0.01% 938
2018
Q3 		$1.49M Buy
26,906
+6,800
+34% +$350K 0.01% 782
2018
Q2 		$946K Sell
20,106
-600
-3% -$24.7K 0.01% 968
2018
Q1 		$749K Buy
+20,706
New +$728K ﹤0.01% 1049

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mackay Shields LLC's RGEN Position: Q3 2020 in Review

Mackay Shields LLC sold out of Repligen (RGEN) in Q3 2020, closing a stake of 6,200 shares — an estimated $766K sold.

Mackay Shields LLC first reported a position in RGEN in Q1 2018 and held it in 10 quarters. The position peaked at $3.38M in Q2 2019. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Mackay Shields LLC reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 6,200 Repligen shares in Q3 2020, an estimated $766K.
  • Mackay Shields LLC first reported a position in Repligen in Q1 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Repligen position peaked at $3.38M in Q2 2019.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.